developing national guidelines for the clinical management of opioid use disorder

For example, CRISM is currently doing a study called 'OPTIMA - Optimizing patient centered-care'. This randomized control trial compares models of care in the management of problematic prescription opioid use.

This study will evaluate the effectiveness of two different treatment approaches in reducing problematic opioid use. The resulting information will be used in patient care to improve overall health outcomes.

Harm Reduction Evidence

CRISM's evidence is used to help support actions to reduce the negative consequences of drug and substance use.

CRISM supports the development of harm reduction measures OR actions by collecting evidence from harm reduction practices delivered in:

clinics

communities

academic research settings

Enforcement Evidence

Evidence is used to address illegal drug production, supply and distribution.

For example, the Canada Border Services Agency (CBSA):

collects data

monitors trends

produces reports

performs intelligence analysis

The evidence they assemble helps them in their efforts against prohibited and controlled substances.